|
HMGB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.655610E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.960200E-01 |
| Normal-vs-Stage2 |
1.007630E-02 |
| Normal-vs-Stage3 |
4.936000E-02 |
| Normal-vs-Stage4 |
9.645900E-02 |
| Stage1-vs-Stage2 |
8.064700E-03 |
| Stage1-vs-Stage3 |
5.595900E-02 |
| Stage1-vs-Stage4 |
1.077960E-01 |
| Stage2-vs-Stage3 |
2.292400E-01 |
| Stage2-vs-Stage4 |
2.047200E-01 |
| Stage3-vs-Stage4 |
8.464200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.075800E-01 |
| Normal-vs-AfricanAmerican |
1.822440E-01 |
| Normal-vs-Asian |
9.551000E-01 |
| Caucasian-vs-AfricanAmerican |
4.199200E-01 |
| Caucasian-vs-Asian |
3.431600E-01 |
| AfricanAmerican-vs-Asian |
1.927240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.840000E-01 |
| Normal-vs-Female |
1.506420E-01 |
| Male-vs-Female |
6.946600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.747200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.153560E-01 |
| Normal-vs-Age(61-80Yrs) |
6.464900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.665630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.465600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.702700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.954200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.251240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.452000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.064800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.240000E-02 |
| Classical-VS-Follicular |
1.84596999999176E-05 |
| Classical-VS-Other |
9.657600E-01 |
| Classical-VS-Normal |
6.533200E-01 |
| Tall-VS-Follicular |
1.955050E-01 |
| Tall-VS-Other |
2.838800E-01 |
| Tall-VS-Normal |
7.978300E-02 |
| Follicular-VS-Other |
1.554840E-01 |
| Follicular-VS-Normal |
6.439300E-04 |
| Other-VS-Normal |
8.198000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.027700E-02 |
| Normal-vs-N1 |
6.597000E-01 |
| N0-vs-N1 |
1.097580E-01 |
|
|
